2,4,6-Trimethylpyridine → N-(4-(((2-cyanobenzo[d]thiazol-6-yl)oxy)methyl)phenyl)-3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanamide

HRID 921509ノート

反応式

HRID 921509 の反応式
Br[CH2:2][C:3]1[CH:8]=[CH:7][C:6]([NH:9][C:10](=[O:26])[CH2:11][C:12]([CH3:25])([C:14]2[C:19](=[O:20])[C:18]([CH3:21])=[C:17]([CH3:22])[C:16](=[O:23])[C:15]=2[CH3:24])[CH3:13])=[CH:5][CH:4]=1.[OH:27][C:28]1[CH:38]=[CH:37][C:31]2[N:32]=[C:33]([C:35]#[N:36])[S:34][C:30]=2[CH:29]=1.N1C(C)=CC(C)=CC=1C>C1COCC1>[C:35]([C:33]1[S:34][C:30]2[CH:29]=[C:28]([O:27][CH2:2][C:3]3[CH:8]=[CH:7][C:6]([NH:9][C:10](=[O:26])[CH2:11][C:12]([CH3:25])([C:14]4[C:19](=[O:20])[C:18]([CH3:21])=[C:17]([CH3:22])[C:16](=[O:23])[C:15]=4[CH3:24])[CH3:13])=[CH:5][CH:4]=3)[CH:38]=[CH:37][C:31]=2[N:32]=1)#[N:36]

参加物

5

実験手順

A mixture of N-(4-(bromomethyl)phenyl)-3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanamide (0.23 g, 0.57 mmol), 6-hydroxy-2-cyanobenzothiazole (0.15 g, 0.86 mmol), 2,4,6-collidine (0.125 ml) and Ag2CO3 (0.24 g, 0.86 mmol) in 15 ml of dry THF was stirred at room temperature over night. After removal of solid by filtration, the compound was purified by silica chromatography using heptane and ethyl acetate as eluent to give a yield of 40%. The product was further purified by HPLC to remove small contamination of 2-cyano-6-hydroxybenzothiazole. 1H NMR (300 MHz, CD2Cl2) δ 7.4-7.5 (m, 3H), 7.35-7.42 (m, 2H), 7.32 (dd, 1H), 7.25 (s, br, 1H, NH), 7.18 (dd, 1H), 5.15 (s, 2H, CH2O), 2.99 (s, 2H, CH2), 2.14 (s, 3H, CH3), 1.92 (s, 6H, CH3), 1.47 (s, 6H, CH3). MS (m/e): 514.2 (M+).

後処理

  1. customAfter removal of solid
  2. filtrationby filtration
  3. customthe compound was purified by silica chromatography
  4. customto give a yield of 40%
  5. customThe product was further purified by HPLC
  6. customto remove small contamination of 2-cyano-6-hydroxybenzothiazole

出典と根拠

ORDレコード
ord-0f495beec1d0428fb1e347dba9f0e192
出典データセット
uspto-grants-2016_03
特許番号
US09273343B2

反応ノート

読み込み中…